Literature DB >> 3680052

Collagen type II in the otic extracellular matrix. Effect on inner ear development.

T R Van de Water1, V Galinovic-Schwartz.   

Abstract

Immunocytochemistry was used to demonstrate type II collagen distribution during normal development of the mouse inner ear and in two malformed inner ears. Patterns of inner ear abnormalities and type II collagen distribution were compared between the malformed labyrinth of a mouse mutation (disproportionate micromelia, Dmm) and otic explants exposed to the teratogenic action of an L-proline analog, L-azetidine-2-carboxylic acid (LACA). The results suggest that type II collagen is an important constituent of the developing inner ear's extracellular matrix. Disruptions of the spatial and temporal pattern of collagen type II can adversely affect morphogenesis of the inner ear. A common mechanism of action is postulated for the causation of both the genetic and teratogen-induced inner ear malformations (i.e. disruption of the secretion of collagens to the otic extracellular matrix).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680052     DOI: 10.1016/0378-5955(87)90181-x

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  3 in total

1.  Stepwise enforcement of the notochord and its intersection with the myoseptum: an evolutionary path leading to development of the vertebra?

Authors:  Sindre Grotmol; Harald Kryvi; Roger Keynes; Christel Krossøy; Kari Nordvik; Geir K Totland
Journal:  J Anat       Date:  2006-09       Impact factor: 2.610

2.  Molecular markers for cell types of the inner ear and candidate genes for hearing disorders.

Authors:  S Heller; C A Sheane; Z Javed; A J Hudspeth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  Expression and function of scleraxis in the developing auditory system.

Authors:  Zoe F Mann; Weise Chang; Kyu Yup Lee; Kelly A King; Matthew W Kelley
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.